Talphera (TLPH)

• Market cap: $49.4M
• 1 day: -2.75%
• 5 days: -9.4%
• 1 month: -13.82%
• 3 months: -16.54%
• 6 months: 110.32%
• Year to date: -8.62%
• 1 year: 76.67%
• 5 years: -96.1%
• 10 years: -98.31%
• Sector: Healthcare
• Industry: Drug Manufacturers - Specialty & Generic

About: Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. The Company's nafamostat product candidates include Niyad and LTX-608. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.

Employees: 13